Loading insider details...
Beta
Latest Form 4 (Aug 10, 2026): Purchase of 6,000 BLSM shares, $96.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Purchase | 6,000 | $96.0K |
| Jun 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 6,030 | n/a |
| Jun 17, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,030 | n/a |
| Jun 11, 2026 | Design Therapeutics, Inc. (DSGN) | Grant/Award | 30,000 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 22, 2026 | ANAPTYSBIO, INC (ANAB) | Disposition to Issuer | 15,000 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 2, 2026 | ANAPTYSBIO, INC (ANAB) | Sale | 12,596 | $701.7K |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 5,500 | n/a |
| Dec 23, 2025 | ANAPTYSBIO, INC (ANAB) | Other (see footnotes) | 11,068 | $564.5K |